Preprint · OA
via OpenAlex
Pharmacological Targeting of Senescence with Senolytics as a New Therapeutic Strategy for Neurodegeneration
Miriam Richardson, Des R. Richardson
Molecular Pharmacology · 2023 · ▲ 47 citations
Abstract
This Molecular Pharmacology 2023 review examines the use of senolytics(definition) to target cellular senescence(definition) as a therapeutic strategy for neurodegeneration.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1124/molpharm.123.000803
- Canonical
- link ↗
- Fetched
- 2026-09-19 MST
Cite this
APA
Richardson, M., & Richardson, D.R. (2023). Pharmacological Targeting of Senescence with Senolytics as a New Therapeutic Strategy for Neurodegeneration. <em>Molecular Pharmacology</em>. https://doi.org/10.1124/molpharm.123.000803
Vancouver
Richardson M, Richardson DR. Pharmacological Targeting of Senescence with Senolytics as a New Therapeutic Strategy for Neurodegeneration. Molecular Pharmacology. 2023. doi:10.1124/molpharm.123.000803.
BibTeX
@unpublished{miriam2023Pharma,
title = {Pharmacological Targeting of Senescence with Senolytics as a New Therapeutic Strategy for Neurodegeneration},
author = {Miriam Richardson and Des R. Richardson},
journal = {Molecular Pharmacology},
year = {2023},
doi = {10.1124/molpharm.123.000803},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Naunyn-Schmiedeberg s Archives of Pharmacology 2026
Citation only
Pharmacological targeting of the senescence-associated secretory phenotype in atherosclerosis: therapeutic potential of senolytics and senomorphics
International Journal of Sciences and Innovation Engineering 2025
Open access · CC-BY
Pharmacology of Senolytics: Targeting Cellular Aging in Chronic Diseases
Brain Research 2024
Citation only
Proteostasis disruption and senescence in Alzheimer’s disease pathways to neurodegeneration
Elsevier eBooks 2022
Citation only
A geroscience approach for osteosarcopenia: Autophagy and senescence as therapeutic targets
Nature Reviews Drug Discovery 2019
Preprint · OA
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
International Journal of Molecular Sciences 2021
Open access · CC-BY